TY - JOUR AU - Selasche, S. J. PY - 2000 DA - 2000// TI - Epidemiology of actinic keratoses and squamous cell carcinoma JO - J Am Acad Dermatol VL - 42 UR - https://doi.org/10.1067/mjd.2000.103342 DO - 10.1067/mjd.2000.103342 ID - Selasche2000 ER - TY - JOUR AU - Ackerman, A. B. PY - 2003 DA - 2003// TI - Solar keratosis is squamous cell carcinoma JO - Arch Dermatol VL - 139 ID - Ackerman2003 ER - TY - JOUR AU - Röwert-Huber, J. AU - Patel, M. J. AU - Forschner, T. PY - 2007 DA - 2007// TI - Actinic keratosis is an early in situ squamous cell carcinoma: a proposal for reclassification JO - Br J Dermatol VL - 156 UR - https://doi.org/10.1111/j.1365-2133.2007.07860.x DO - 10.1111/j.1365-2133.2007.07860.x ID - Röwert-Huber2007 ER - TY - JOUR AU - Gupta, A. K. PY - 2002 DA - 2002// TI - The management of actinic keratoses in the United States wih topical fluorouracil: a pharmacoeconomic evaluation JO - Cutis VL - 70 ID - Gupta2002 ER - TY - JOUR AU - Lebwohl, M. AU - Dinehart, S. AU - Whiting, D. PY - 2004 DA - 2004// TI - Imiquimod 5% cream for the treatment of actinic keratosis: results from two phase III, randomized double-blind, parallel group, vehicle-controlled trials JO - J Am Acad Dermatol VL - 50 UR - https://doi.org/10.1016/j.jaad.2003.12.010 DO - 10.1016/j.jaad.2003.12.010 ID - Lebwohl2004 ER - TY - JOUR AU - Rivers, J. K. AU - Arlette, J. AU - Shear, N. PY - 2002 DA - 2002// TI - Topical treatment of actinic keratoses with 3.0% diclofenac in 2, 5% hyaluronic gel JO - Br J Dermatol VL - 146 UR - https://doi.org/10.1046/j.1365-2133.2002.04561.x DO - 10.1046/j.1365-2133.2002.04561.x ID - Rivers2002 ER - TY - JOUR AU - Campione, E. AU - Diluvio, L. AU - Paterno, E. J. AU - Chimenti, S. PY - 2010 DA - 2010// TI - Topical treatment of actinic keratoses with piroxicam 1% gel. A preliminary open-label study utilizing a new clinical score JO - Am J Clin Dermatol VL - 11 UR - https://doi.org/10.2165/11311170-000000000-00000 DO - 10.2165/11311170-000000000-00000 ID - Campione2010 ER - TY - JOUR AU - Cuevas, P. AU - Arrazola, J. M. PY - 2005 DA - 2005// TI - Treatment of basal cell carcinoma with topical dobesilate JO - J Am Acad Dermatol VL - 53 UR - https://doi.org/10.1016/j.jaad.2005.04.014 DO - 10.1016/j.jaad.2005.04.014 ID - Cuevas2005 ER - TY - JOUR AU - Fernandez, I. S. AU - Cuevas, P. AU - Angulo, J. PY - 2010 DA - 2010// TI - Gentisic acid, a compound associated with plant defence and a metabolite of aspirin, heads a new class of in vivo FGF inhibitor JO - J Biol Chem VL - 285 UR - https://doi.org/10.1074/jbc.M109.064618 DO - 10.1074/jbc.M109.064618 ID - Fernandez2010 ER - TY - JOUR AU - Folkman, J. PY - 1995 DA - 1995// TI - Angiogenesis in cancer, vascular, rheumatoid and other disease JO - Nat Med VL - 1 UR - https://doi.org/10.1038/nm0195-27 DO - 10.1038/nm0195-27 ID - Folkman1995 ER - TY - JOUR AU - Strieth, S. AU - Hartschuh, W. AU - Pilz, L. AU - Fusening, N. E. PY - 2000 DA - 2000// TI - Angiogenic swith occurs late in squamous cell carcinomas of human skin JO - Br J Cancer VL - 82 UR - https://doi.org/10.1054/bjoc.1999.0969 DO - 10.1054/bjoc.1999.0969 ID - Strieth2000 ER - TY - JOUR AU - Wang, Y. AU - Becker, D. PY - 1997 DA - 1997// TI - Antisense targeting of basic fibroblast growth factor receptor-1 in human melanomas blocks intratumoral angiogenesis and tumor growth JO - Nat Med VL - 8 UR - https://doi.org/10.1038/nm0897-887 DO - 10.1038/nm0897-887 ID - Wang1997 ER - TY - JOUR AU - Arbiser, J. L. AU - Byers, H. R. AU - Cohen, C. AU - Arbeits, J. PY - 2000 DA - 2000// TI - Altered basic fibroblast growth factor expression in common epidermal neoplasms: examination with in situ hybridization and immunohistochemistry JO - J Am Acad Dermatol VL - 42 UR - https://doi.org/10.1067/mjd.2000.104792 DO - 10.1067/mjd.2000.104792 ID - Arbiser2000 ER - TY - CHAP AU - Cuevas, P. AU - De Miguel, R. AU - Espinoza, W. PY - 2010 DA - 2010// TI - Antimelanoma effect of a synthetic inhibitor of fibroblast growth factor (FGF) [abstract no° 79 plus Poster] BT - 13th World Congress on Cancers of the Skin ID - Cuevas2010 ER -